Abstract
Prescriptions for selective serotonin reuptake inhibitor (SSRI) sertraline accounted for an extra £113m during 2020 compared with 2019, research published in DARU Journal of Pharmaceutical Sciences has shown. The authors say the increase was mainly attributed to shortages of the active pharmaceutical ingredient (API) and the resulting significant increase in the cost of generic medicines during […]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
